In the obesity host, increased SREBP-1 is linked to ovarian cancer progression and metastasis (126) and meditates malignant characteristics, such as cell proliferation, migration, invasion, and tumor growth (127). Here, SREBF1 is linked to obesity due to melanocortin 4 receptor deficiency.